Home Page  / Our Products  / HEBERPROT-P

HEBERPROT-P contains human epidermal growth factor which is produced by recombinant DNA technology. When directly injected into the wound, this growth factor ensures healing of deep and serious diabetic foot ulcers that are induced by diabetes and may usually lead to amputation of the foot. It has gained an important place among the treatments of diabetic foot ulcers and those addressing the prevention of diabetes-induced foot amputation (removal). When applied to diabetic foot ulcers associated with impaired blood flow into the tissue or nerve damage, HEBERPROT-P provides a fast, safe and effective wound healing process. In addition, HEBERPROT-P has significantly reduced the rates of foot amputation caused by diabetes-induced foot ulcers in 26 countries where it is already registered.

Information in our website will not replace information provided by a physician or pharmacist. Hasbiotech does not assume any legal responsibility for cases arising out of the abuse or misuse of information and references contained hereunder. The information offered in this website is intended for target users and may not be distributed to third parties or copied by others. Unauthorized use of registered marks and texts in this website is not allowed. By using this website, all users are deemed to have accepted this legal warning.

You may access the remaining part of the website only after confirming that you are a healthcare professional (physician, pharmacist, dentist etc.).

Click the “I agree” button if you are confirming that you are a healthcare professional (physician, pharmacist, dentist etc.). Otherwise, click the “I do not agree” button.
I agree I do not agree